Compare CYBN & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYBN | MVBF |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.9M | 333.7M |
| IPO Year | N/A | N/A |
| Metric | CYBN | MVBF |
|---|---|---|
| Price | $6.62 | $27.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $74.50 | $27.60 |
| AVG Volume (30 Days) | ★ 626.1K | 76.3K |
| Earning Date | 11-13-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | N/A | ★ 73.99 |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | ★ $167,853,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.06 |
| P/E Ratio | ★ N/A | $11.37 |
| Revenue Growth | N/A | ★ 18.75 |
| 52 Week Low | $4.81 | $15.59 |
| 52 Week High | $10.73 | $28.72 |
| Indicator | CYBN | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 62.40 |
| Support Level | $5.70 | $26.52 |
| Resistance Level | $6.20 | $28.72 |
| Average True Range (ATR) | 0.35 | 0.69 |
| MACD | 0.08 | 0.12 |
| Stochastic Oscillator | 85.82 | 72.70 |
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.